Yamashita, T.; Shimakami, T.; Nio, K.; Terashima, T.; Okajima, M.; Taniguchi, T.; Wada, T.; Honda, M.; Gabata, T.; Ota, K.;
et al. Preexisting Humoral Immunity Cross-Reacting with SARS-CoV-2 Might Prevent Death Due to COVID-19 in Critical Patients. J. Clin. Med. 2022, 11, 3870.
https://doi.org/10.3390/jcm11133870
AMA Style
Yamashita T, Shimakami T, Nio K, Terashima T, Okajima M, Taniguchi T, Wada T, Honda M, Gabata T, Ota K,
et al. Preexisting Humoral Immunity Cross-Reacting with SARS-CoV-2 Might Prevent Death Due to COVID-19 in Critical Patients. Journal of Clinical Medicine. 2022; 11(13):3870.
https://doi.org/10.3390/jcm11133870
Chicago/Turabian Style
Yamashita, Taro, Tetsuro Shimakami, Kouki Nio, Takeshi Terashima, Masaki Okajima, Takumi Taniguchi, Takashi Wada, Masao Honda, Toshifumi Gabata, Kenji Ota,
and et al. 2022. "Preexisting Humoral Immunity Cross-Reacting with SARS-CoV-2 Might Prevent Death Due to COVID-19 in Critical Patients" Journal of Clinical Medicine 11, no. 13: 3870.
https://doi.org/10.3390/jcm11133870
APA Style
Yamashita, T., Shimakami, T., Nio, K., Terashima, T., Okajima, M., Taniguchi, T., Wada, T., Honda, M., Gabata, T., Ota, K., Yanagihara, K., & Kaneko, S.
(2022). Preexisting Humoral Immunity Cross-Reacting with SARS-CoV-2 Might Prevent Death Due to COVID-19 in Critical Patients. Journal of Clinical Medicine, 11(13), 3870.
https://doi.org/10.3390/jcm11133870
